Consistently, results from previous studies in other types of cancer, including uveal melanoma, clear-cell renal cell carcinoma, gastric adenocarcinoma, colorectal cancer, and non-small-cell lung cancer, also documented a significant decrease in tumor BAP1 expression35–39. This evidence concerns the gene BAP1 and cancer.